Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 27;17(6):701.
doi: 10.3390/pharmaceutics17060701.

Quality by Design and In Silico Approach in SNEDDS Development: A Comprehensive Formulation Framework

Affiliations
Review

Quality by Design and In Silico Approach in SNEDDS Development: A Comprehensive Formulation Framework

Sani Ega Priani et al. Pharmaceutics. .

Abstract

Background/Objectives: The Self-Nanoemulsifying Drug Delivery System (SNEDDS) has been widely applied in oral drug delivery, particularly for poorly water-soluble compounds. The successful development of SNEDDS largely depends on the precise composition of its components. This narrative review provides an in-depth analysis of Quality by Design (QbD), Design of Experiment (DoE), and in silico approach applications in SNEDDS development. Methods: The review is based on publications from 2020 to 2025, sourced from reputable scientific databases (Pubmed, Science direct, Taylor and francis, and Scopus). Results: Quality by Design (QbD) is a systematic and scientific approach that enhances product quality while ensuring the robustness and reproducibility of SNEDDS, as outlined in the Quality Target Product Profile (QTPP). DoE was integrated into the QbD framework to systematically evaluate the effects of predefined factors, particularly Critical Material Attributes (CMAs) and Critical Process Parameters (CPPS), on the desired responses (Critical Quality Attributes/CQA), ultimately leading to the identification of the optimal SNEDDS formulation. Various DoEs, including the mixture design, response surface methodology, and factorial design, have been widely applied to SNEDDS formulations. The experimental design facilitates the analysis of the relationship between CQA and CMA/CPP, enabling the identification of optimized formulations with enhanced biopharmaceutical, pharmacokinetic, and pharmacodynamic profiles. As an essential addition to this review, in silico approach emerges as a valuable tool in the development of SNEDDS, offering deep insights into self-assembly dynamics, molecular interactions, and emulsification behaviour. By integrating molecular simulations with machine learning, this approach enables rational and efficient optimization. Conclusions: The integration of QbD, DoE, and in silico approaches holds significant potential in the development of SNEDDS. These strategies enable a more efficient, rational, and predictive formulation process.

Keywords: SNEDDS; design of experiment; molecular modelling; optimization; quality by design.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Illustration of SNEDDS (created in BioRender https://BioRender.com/e1zgkjm accessed on 23 May 2025).
Figure 2
Figure 2
QbD stages based on ICH Q8 (R2).
Figure 3
Figure 3
Relationship between CMAs, CPPs, and CQAs in SNEDDS optimization.

Similar articles

References

    1. Tucker G., DeSilva B., Dressman J., Ito M., Kumamoto T., Mager D., Mahler H.-C., der Zee A.H.M.-V., Pauletti G.M., Sasaki H., et al. Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective. J. Pharm. Sci. 2016;105:2489–2497. doi: 10.1016/j.xphs.2015.12.001. - DOI - PubMed
    1. Gyawali R., Aryal S., Regmi Y., Rajarajan S. Cocrystallization: An Approach to Improve Bioavailability by Altering Physicochemical Properties of Poorly Soluble API’s. Int. J. Pharm. Pharm. Res. 2021;20:381–397. doi: 10.25166/ijppr.2021.v20i04.28. - DOI
    1. Bhalani D.V., Nutan B., Kumar A., Chandel A.K.S. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines. 2022;10:2055. doi: 10.3390/biomedicines10092055. - DOI - PMC - PubMed
    1. Singh D., Bedi N., Tiwary A.K. Enhancing solubility of poorly aqueous soluble drugs: Critical appraisal of techniques. J. Pharm. Investig. 2018;48:509–526. doi: 10.1007/s40005-017-0357-1. - DOI
    1. Buya A.B., Beloqui A., Memvanga P.B., Préat V. Self-nano-emulsifying drug-delivery systems: From the development to the current applications and challenges in oral drug delivery. Pharmaceutics. 2020;12:1194. doi: 10.3390/pharmaceutics12121194. - DOI - PMC - PubMed

LinkOut - more resources